Land: Australien
Sprog: engelsk
Kilde: Department of Health (Therapeutic Goods Administration)
Pertussis fimbriae 2 + 3; Pertussis filamentous haemagglutinin; Tetanus toxoid; Diphtheria toxoid; Pertactin; Pertussis toxoid
Sanofi-Aventis Australia Pty Ltd
Medicine Registered
ADACEL ® _Pertussis Vaccine - Acellular Combined with Diphtheria and Tetanus Toxoids (Adsorbed)_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about ADACEL ® . It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines, including vaccines, have risks and benefits. Your doctor has weighed the risks of you having ADACEL ® against the benefits they expect it will have. IF YOU HAVE ANY CONCERNS ABOUT THIS VACCINE, ASK YOUR DOCTOR, NURSE OR PHARMACIST. KEEP THIS LEAFLET. YOU MAY NEED TO READ IT AGAIN. WHAT ADACEL ® IS USED FOR ADACEL ® is a vaccine used to help prevent whooping cough (pertussis), tetanus and diphtheria. This vaccine is for use as a booster in persons from the age of 10 years who have previously received childhood immunisation. ADACEL ® is not intended for childhood immunisation. The use of ADACEL ® should be determined on the basis of official recommendations and by your doctor. Whooping cough, tetanus and diphtheria cause significant sickness and sometimes death in unvaccinated infants, children, and adults. _HOW IT WORKS_ ADACEL ® works by causing the body to produce its own protection against whooping cough, tetanus, and diphtheria. It does this by making substances called antibodies in the blood, which fight the bacteria and toxins that cause these diseases. If a vaccinated person comes into contact with these bacteria and toxins, the body is usually ready to destroy them. It usually takes several weeks after vaccination to develop protection against these diseases. A course of whooping cough, tetanus and diphtheria vaccine is usually given during early childhood at 2, 4 and 6 months of age, followed by a booster at 4 years of age. In case of whooping cough, tetanus and diphtheria, a second booster is required at the age of 15-17 years. Most people will produce enough antibodies against these diseases. However, as with all vaccines, 100% p Læs hele dokumentet
SANOFI PASTEUR ADACEL PERTUSSIS VACCINE – ACELLULAR COMBINED WITH DIPHTHERIA AND TETANUS TOXOID (ADSORBED) PAGE 1 OF 9 AUSTRALIAN PRODUCT INFORMATION NAME OF THE MEDICINE ADACEL Pertussis Vaccine-Acellular Combined with Diphtheria and Tetanus Toxoids (Adsorbed) DESCRIPTION ADACEL is a sterile, uniform, cloudy, white suspension for injection. Each 0.5 mL dose of ADACEL contains: 2.5 g pertussis toxoid 5 g pertussis filamentous haemagglutinin 5 g pertussis fimbriae types 2 and 3 3 g pertussis pertactin 2 IU (2 LfU) diphtheria toxoid 20 IU (5 LfU)* tetanus toxoid 1.5 mg aluminium phosphate (equivalent to 0.33mg aluminium) 0.6% v/v phenoxyethanol 0.005mg formaldehyde 0.02mg glutaraldehyde water for injections to 0.5mL *The formulated content of 5LfU per 0.5mL dose of tetanus toxoid is the same as the related product Tripacel ® . The vaccine is prepared from: adsorbed purified and formaldehyde detoxified diphtheria and tetanus toxins; adsorbed purified and glutaraldehyde detoxified pertussis toxin (pertussis toxoid or PT); adsorbed purified and formaldehyde treated filamentous haemagglutinin (FHA); adsorbed purified pertactin (PRN) and fimbriae types 2 and 3 (FIM). ADACEL is an adult/adolescent formulation diphtheria-tetanus-acellular pertussis (dTpa) combination vaccine with reduced content of pertussis toxoid, filamentous haema Læs hele dokumentet